Guide

The RRDi is please to announce that Eric Bakker, ND, is volunteering to serve on the RRDi MAC. Dr. Bakker has an interesting video on Does Candida Cause Rosacea?

"We report a unique case of facial erythema of rosacea that responded to brimonidine gel with effective blanching for two years until the patient developed a paradoxical erythema reaction. This is an adverse reaction physicians should be aware of with continued prescription of brimonidine gel for their rosacea patients." Paradoxical Erythema Reaction of Long-term Topical Brimonidine Gel for the Treatment of Facial Erythema of Rosacea June 2016 | Volume 15 | Issue 6 | Case Report | 763 | Copyright © 2016 Erin Lowe, MSIV and Scott Lim, DO

WebORVOS How to use Google Translate

A document prepared for Allergan’s November 4, 2015 R&D Day presentation is available to download which is primarily about this new Oxymetazoline 1% Cream which may be released next year. David Pascoe has some insightful comments about this document worth reading.

Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea David Pascoe's Comment

medgadget

Wrinkles, rosacea, acne oh my! Colorado’s Own Channel 2 KWGN-TV, POSTED 12:56 PM, JUNE 14, 2016, BY SETH GREGORY

Marshall prof plays role in rosacea research POSTED ON JUNE 17, 2016 BY POINT PLEASANT REGISTER Marshall exercise science professor plays role in new rosacea research The Herald Dispatch, Huntington, WV Marshall prof plays role in rosacea research POSTED ON JUNE 17, 2016 BY POINT PLEASANT REGISTER, Pomeroy, Ohio

Rosacea vs. acne: Differences in symptoms, causes, and treatment By: Devon Andre |Bel Marra Health | Skin Health | Thursday, June 16, 2016

Lupus vs. rosacea, differences in symptoms, causes, and treatment, By: Dr. Victor Marchione | Bel Marra Health | Skin Health | Wednesday, June 08, 2016

Bottled water about to beat soda as most consumed beverage Hadley Malcolm, USA TODAY 11:53 a.m. EDT June 8, 2016

An article published by The Conversation reports, that "two million people are infected with antibiotic-resistant bacteria in the United States each year, and 23,000 people die as a result of these infections." This report also points out, "Dermatologists, for example, prescribe five percent of antibiotics, but make up only one percent of all physicians." Antibiotic resistance is a very serious matter. The same article quotes Tom Frieden, the director of the Centers for Disease Control and Prevention, who said in a press conference on May 26, 2016, "The medicine cabinet is empty for some patients. It is the end of the road for antibiotics unless we act urgently." Perspectives on antibiotic resistance: how we got here, where we’re headed, The Conversation

Devon Andre, Skin Health, Bel Marra Health

It is not uncommon for rosaceans to complain about artificial lights, particularly fluorescent lights, computer screens, etc. Whether any of these types of artificial lights actually trigger rosacea or not is something that should be tested in a double blind, controlled study to answer these type of trigger questions. At any rate, it is fun to watch this scene in Joe vs the Volcano where Tom Hanks says, "Zombie lights, I...I..I, can feel them sucking the juice out of my eyeballs. Suck, suck, suck, suck, suck....gghhoooish!!!" Reply to this Topic There is a reply to this topic button somewhere on the device you are reading this post. More information

PRNewswire

Healio

"Omiganan is a cationic antimicrobial peptide, a first-in-class for rosacea, that is entering into phase 3 trials. In a phase 2 dose-ranging study (N=240),[18] it showed a dose-dependent reduction in inflammatory lesions. The 2.5% formulation resulted in a 40% reduction at week 9. Cutaneous tolerability was good." Hilary Baldwin, MD, What's New in Acne and Rosacea, Medscape Dermatology, April 29, 2016 [last paragraph of the article] Omiganan (CLS001) developed by Cutanea.

Allergan announced that the Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for oxymetazoline HCl cream 1% (Rhofade) for the treatment of persistent facial erythema associated with rosacea in adults. MPR Should be released sometime in 2017. The name Rhofade is mentioned in this article. Allergan Plc (AGN) Brenton L. Saunders on Q2 2016 Results – Earnings Call Transcript A document prepared for Allergan’s November 4, 2015 R&D Day presentation is available to download which is primarily about this new Oxymetazoline 1% Cream which may be released next year. David Pascoe has some insightful comments about this document worth reading. FDA has approved Rhofade.

Marie Claire

Dr. Bernstein volunteers with the RRDi MAC

Dr. Whitney Bowes volunteers on the RRDi MAC

Dr. Whitney Bowe volunteers for the RRDi MAC

Dr. Ben Johnson volunteers on the RRDi MAC

Dr. Ben Johnson volunteers on the RRDi MAC

Dr. Neal Shear volunteers with the RRDi MAC